NEUBASE THERAPEUTICS INC's ticker is NBSE and the CUSIP is 64132K102. A total of 58 filers reported holding NEUBASE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $4,000 | -63.6% | 10,000 | 0.0% | 0.00% | -100.0% |
| Q2 2022 | $11,000 | -42.1% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $19,000 | -32.1% | 10,000 | 0.0% | 0.00% | -50.0% |
| Q4 2021 | $28,000 | -99.9% | 10,000 | +100.0% | 0.00% | 0.0% |
| Q1 2021 | $36,950,000 | +58550.8% | 5,000 | -44.4% | 0.00% | -50.0% |
| Q4 2020 | $63,000 | -99.9% | 9,000 | -18.2% | 0.00% | -63.6% |
| Q3 2020 | $83,490,000 | -26.4% | 11,000 | -15.1% | 0.01% | -31.2% |
| Q2 2020 | $113,375,000 | +31.6% | 12,952 | +7.0% | 0.02% | +6.7% |
| Q1 2020 | $86,152,000 | -1.1% | 12,100 | 0.0% | 0.02% | +25.0% |
| Q4 2019 | $87,120,000 | +161233.3% | 12,100 | +10.0% | 0.01% | +50.0% |
| Q3 2019 | $54,000 | – | 11,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Greenlight Capital | 2,027,027 | $14,169,000 | 0.85% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 103,500 | $723,000 | 0.55% |
| Sio Capital Management, LLC | 293,699 | $2,053,000 | 0.42% |
| GSA CAPITAL PARTNERS LLP | 121,389 | $849,000 | 0.14% |
| Frontier Wealth Management LLC | 145,000 | $1,014,000 | 0.08% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 311,000 | $2,174,000 | 0.06% |
| Oak Grove Capital LLC | 19,175 | $134,000 | 0.04% |
| PREMIER ASSET MANAGEMENT LLC | 14,977 | $105,000 | 0.02% |
| Trexquant Investment LP | 15,479 | $108,000 | 0.01% |
| PILLAR PACIFIC CAPITAL MANAGEMENT LLC | 19,800 | $138,000 | 0.01% |